General Electric Co. agreed to sell its biotechnology business to Danaher Corp. for $21 billion in cash, moving to pay down debt by parting with one of its fastest growing businesses.

from MarketWatch.com - Top Stories https://ift.tt/2Iy8bTP
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/2Iy8bTP
via IFTTT
Kommentare
Kommentar veröffentlichen